EASTERN COOPERATIVE ONCOLOGY GROUP PERFORMANCE STATUS ABNORMAL

EASTERN COOPERATIVE ONCOLOGY GROUP PERFORMANCE STATUS ABNORMAL was reported 133 times

EASTERN COOPERATIVE ONCOLOGY GROUP PERFORMANCE STATUS ABNORMAL is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Estrogen Receptor Antagonist [EPC] 18 0.0004
1 Aromatase Inhibitor [EPC] 26 0.0002
2 Provitamin D2 Compound [EPC] 4 0.0001
3 Programmed Death Receptor-1 Blocking Antibody [EPC] 13 0.0001
4 Calcineurin Inhibitor Immunosuppressant [EPC] 16 0.0001
5 Calcium [EPC] 15 0.0001
6 Expectorant [EPC] 18 0.0001
7 CD20-directed Cytolytic Antibody [EPC] 16 0.0001
8 Bile Acid [EPC] 1 0.0000
9 Microtubule Inhibitor [EPC] 7 0.0000
10 Platinum-based Drug [EPC] 11 0.0000
11 Kinase Inhibitor [EPC] 21 0.0000
12 RANK Ligand Inhibitor [EPC] 6 0.0000
13 Proteasome Inhibitor [EPC] 3 0.0000
14 Janus Kinase Inhibitor [EPC] 4 0.0000
15 Polyene Antifungal [EPC] 1 0.0000
16 Serotonin-3 Receptor Antagonist [EPC] 3 0.0000
17 Dihydropyridine Calcium Channel Blocker [EPC] 7 0.0000
18 Corticosteroid [EPC] 22 0.0000
19 Nonsteroidal Anti-inflammatory Drug [EPC] 18 0.0000
20 HER2/neu Receptor Antagonist [EPC] 1 0.0000
21 Topoisomerase Inhibitor [EPC] 1 0.0000
22 Vitamin B12 [EPC] 4 0.0000
23 Factor Xa Inhibitor [EPC] 3 0.0000
24 Vascular Endothelial Growth Factor Inhibitor [EPC] 2 0.0000
25 Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] 1 0.0000
26 Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC] 1 0.0000
27 Histamine-2 Receptor Antagonist [EPC] 1 0.0000
28 Angiotensin Converting Enzyme Inhibitor [EPC] 1 0.0000
29 Nucleoside Metabolic Inhibitor [EPC] 2 0.0000
30 alpha-Adrenergic Blocker [EPC] 1 0.0000
31 Leukocyte Growth Factor [EPC] 1 0.0000
32 Folate Analog Metabolic Inhibitor [EPC] 3 0.0000
33 Azole Antifungal [EPC] 1 0.0000
34 Xanthine Oxidase Inhibitor [EPC] 1 0.0000
35 Thalidomide Analog [EPC] 3 0.0000
36 Benzodiazepine [EPC] 2 0.0000